Contact Us
 • 
Home
Search 

Clinical Trials > RESILIENT  

  • Information
  • Sites - Open
RESILIENT   

Title

RandomisEd, controlled, double blind Study to assess mechanistic effects of combination therapy of dapagliflozin with Exenatide QW versus dapagliflozin alone in obese (BMI>30 kg/m2) patients with Type 2 diabetes mellitus.


Basic Trial Information

Phase Type Status Age Sponsor Protocol IDs Recruitment
IV Open University of Liverpool 0

Trial Start Date

06/10/2017


Trial Coordinator

Julie Perry


Trial Coordinator Email Address

jperry@liverpool.ac.uk


Trial Coordinator Contact No

0151 795 8577



UK: ENGLAND

  • , MARIARC (Graham Kemp)
  • Liverpool, University Hospital Aintree (Daniel Cuthbertson)